Toll-like receptors pathway in common variable immune deficiency (CVID) and X-linked agammaglobulinemia (XLA)

被引:0
|
作者
Parsova Tavasolian
Laleh Sharifi
Asghar Aghamohammadi
Farshid Noorbakhsh
Rouzbeh Sanaei
Mahsima Shabani
Nima Rezaei
机构
[1] Tehran University of Medical Sciences,Department of Immunology, School of Medicine
[2] Tehran University of Medical Sciences,Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center
[3] Universal Scientific Education and Research Network (USERN),Primary Immunodeficiency Diseases Network (PIDNet)
[4] Iran University of Medical Sciences,Department of Immunology, School of Medicine
[5] Universal Scientific Education and Research Network (USERN),International Hematology/Oncology of Pediatrics Experts (IHOPE)
[6] Universal Scientific Education and Research Network (USERN),Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA)
[7] Children’s Medical Center Hospital,undefined
来源
European Cytokine Network | 2018年 / 29卷
关键词
CVID; XLA; TLR; TNF-α; IFN-α;
D O I
暂无
中图分类号
学科分类号
摘要
Common variable immunodeficiency (CVID) and X-linked agammaglobulinemia (XLA) are two major humoral immunodeficiencies, causing a high rate of early age mortality in children. In order to identifiy the possible factors involved in the pathogenesis of CVID and XLA, recent studies have focused on Toll-like receptors (TLRs) and demonstrate the defects in different TLR pathways in immune cells of CVID and XLA patients. Herein, we measured TLR-4 and TLR-9 RNA levels and consequently TNF-α and IFN-α production in peripheral blood mononuclear cells (PBMCs) of patients with CVID and XLA. Contrary to healthy individuals, TLR-9 expression was not significantly increased after ligand stimulation, whereas ligand-induced TLR-4 expression was not significantly different from that in healthy control PBMCs. Lipopolysaccharide (LPS)-stimulated TNF-α production was significantly reduced in patients compared to controls, whereas IFN-α production was increased in all groups after CpG stimulation without any significant inter-group difference. Our data suggest that defects in TLR-9 activated pathways may be a result of the decreased TLR-9 expression, although TLR-9 is not the only modulator of IFN-α production in these patients. On the other hand, impaired signaling in TLR-4 activated pathways which results in significant reduction in TNF-α production are not related to a defect in TLR-4 expression.
引用
收藏
页码:153 / 158
页数:5
相关论文
共 50 条
  • [1] Toll-like receptors pathway in common variable immune deficiency (CVID) and X-linked agammaglobulinemia (XLA)
    Tavasolian, Parsova
    Sharifi, Laleh
    Aghamohammadi, Asghar
    Noorbakhsh, Farshid
    Sanaei, Rouzbeh
    Shabani, Mahsima
    Rezaei, Nima
    EUROPEAN CYTOKINE NETWORK, 2018, 29 (04) : 153 - 158
  • [2] Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy
    Viti, Raffaella
    Marcellusi, Andrea
    Capone, Alessandro
    Matucci, Andrea
    Vultaggio, Alessandra
    Pignata, Claudio
    Spadaro, Giuseppe
    Vacca, Angelo
    Marasco, Carolina
    Agostini, Carlo
    Mennini, Francesco Saverio
    CLINICAL DRUG INVESTIGATION, 2018, 38 (10) : 955 - 965
  • [3] Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy
    Raffaella Viti
    Andrea Marcellusi
    Alessandro Capone
    Andrea Matucci
    Alessandra Vultaggio
    Claudio Pignata
    Giuseppe Spadaro
    Angelo Vacca
    Carolina Marasco
    Carlo Agostini
    Francesco Saverio Mennini
    Clinical Drug Investigation, 2018, 38 : 955 - 965
  • [4] The Frequency of Antibiotic Use from 1010 Visits in Common Variable Immunodeficiency (CVID) and X-linked Agammaglobulinemia (XLA) Patients Under Intravenous Immunoglobulin (IVIG) Treatment
    Pereira, Mariana de Gouveia
    Silva, Ronnis M.
    Tranquillini Goncalves, Tessa Rachel
    Rota, Rafael
    Costa Carvalho, Beatriz Tavares
    JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 : S122 - S122
  • [5] Toll-like receptor signaling is impaired in dendritic cells from patients with X-linked agammaglobulinemia
    Taneichi, Hiromichi
    Kanegane, Hirokazu
    Sira, Mostafa Mohamed
    Futatani, Takeshi
    Agematsu, Kazunaga
    Sako, Masahiro
    Kaneko, Hideo
    Kondo, Naomi
    Kalisho, Tsuneyasu
    Miyawaki, Toshio
    CLINICAL IMMUNOLOGY, 2008, 126 (02) : 148 - 154
  • [6] VARIABLE EXPRESSION OF B-CELL FUNCTION IN FAMILIES WITH X-LINKED AGAMMAGLOBULINEMIA (XLA)
    PYUN, KH
    OCHS, HD
    YANG, XQ
    WEDGWOOD, RJ
    PEDIATRIC RESEARCH, 1987, 21 (04) : A316 - A316
  • [7] Immune responses to oral polio vaccine (OPV) in patients with X-linked agammaglobulinemia (XLA)
    Wu, Y.
    Mao, H. W.
    Chan, S. M.
    Lam, K. T.
    Tu, W.
    Lau, Y. L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1242 - 1242
  • [8] Immune responses to oral polio vaccine (OPV) in patients with X-linked agammaglobulinemia (XLA)
    Wu, Y.
    Mao, H. W.
    Chan, S. M.
    Lam, K. T.
    Tu, W.
    Lau, Y. L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 700 - 701
  • [9] COVID-19 and X-linked agammaglobulinemia (XLA) - insights from a monogenic antibody deficiency
    Ponsford, Mark J.
    Shillitoe, Benjamin M. J.
    Humphreys, Ian R.
    Gennery, Andrew R.
    Jolles, Stephen
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 21 (06) : 525 - 534
  • [10] Differences in Pulmonary Complications in Common Variable Immunodeficiency and X-Linked Agammaglobulinemia
    Weinberger, Tamar
    Maglione, Paul
    Cunningham-Rundles, Charlotte
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB111 - AB111